Arcus Biosciences
RCUS
RCUS
185 hedge funds and large institutions have $1.02B invested in Arcus Biosciences in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 62 increasing their positions, 68 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
185
Holders Change
-2
Holders Change %
-1.07%
% of All Funds
2.71%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
26
Increased
62
Reduced
68
Closed
25
Calls
$14.5M
Puts
$7.26M
Net Calls
+$7.26M
Net Calls Change
+$510K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$26.8M |
| 2 |
2
Point72 Asset Management
Stamford,
Connecticut
|
$14.7M |
| 3 |
3
BlackRock
New York
|
$192M |
| 4 |
SCM
4
Suvretta Capital Management
New York
|
$18.3M |
| 5 |
LGM
5
Logos Global Management
San Francisco,
California
|
$6.21M |
